{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:36:08Z","timestamp":1753889768718,"version":"3.41.2"},"reference-count":53,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R15CA213103"],"award-info":[{"award-number":["R15CA213103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CBC"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Solidago virgaurea (Asteraceae), has been used for more than 700 years for treating cystitis, chronic nephritis, urolithiasis, rheumatism, and inflammatory diseases. However, the antidiabetic activity of Solidago virgaurea has been rarely studied.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Three extracts of Solidago virgaurea were prepared and their antidiabetic potentials were evaluated by various cell-free, cell-based, and in vivo studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We found that the Solidago virgaurea contained multiple bioactive phytochemicals based on the GC-MS analysis. The Solidago virgaurea extracts effectively inhibited the functions of the carbohydrate digestive enzyme (\u03b1-glucosidase) and protein tyrosine phosphatase 1B (PTP1B), as well as decrease the amount of advanced glycation end products (AGEs). In the L6 myotubes, the Solidago virgaurea methanolic extract remarkably enhanced the glucose uptake via the upregulation of glucose transporter type 4 (GLUT4). The extract also significantly downregulated the expression of PTP1B. In the streptozotocin-nicotinamide induced diabetic mice, the daily intraperitoneal injection of 100 mg\/kg Solidago virgaurea methanolic extract for 24 days, substantially lowered the postprandial blood glucose level with no obvious toxicity. The extract\u2019s anti-hyperglycemic effect was comparable to that of the glibenclamide treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our findings suggested that the Solidago virgaurea extract might have great potential in the prevention and treatment of diabetes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573407218666220615143502","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T09:19:42Z","timestamp":1655371182000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vitro and In vivo Evaluation of the Antidiabetic Activity of Solidago virgaurea\nExtracts"],"prefix":"10.2174","volume":"19","author":[{"given":"Lin","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&amp;M University, College\nStation, Texes-78363, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda Andleeb","family":"Zehra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&amp;M University, College\nStation, Texes-78363, USA"},{"name":"Department of Biochemistry, Faculty of Health Sciences, Hazara University, Mansehra-\n21300, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prapanna","family":"Bhattarai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&amp;M University, College\nStation, Texes-78363, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&amp;M University, College\nStation, Texes-78363, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&amp;M University, College\nStation, Texes-78363, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahida","family":"Parveen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Abdul Wali Khan University, Mardan-23200, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Sajid","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Health Sciences, Hazara University, Mansehra-\n21300, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539:AIDDIA668>3.0.CO;2-S","volume":"15","author":"Alberti K.G.","year":"1998","unstructured":"Alberti K.G.; Zimmet P.Z.; Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998,15(7),539-553","journal-title":"Diabet Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"Association A.D.","year":"2014","unstructured":"Association A.D.; Diagnosis and classification of diabetes mellitus. Diabetes Care 2014,37(Suppl. 1),S81-S90","journal-title":"Diabetes Care"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/ph12040152","volume":"12","author":"Vieira R.","year":"2019","unstructured":"Vieira R.; Souto S.B.; S&#xE1;nchez-L&#xF3;pez E.; Machado A.L.; Severino P.; Jose S.; Santini A.; Fortuna A.; Garc&#xED;a M.L.; Silva A.M.; Souto E.B.; Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome-review of classical and new compounds: Part-I. Pharmaceuticals (Basel) 2019,12(4),152","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.diabres.2004.09.004","volume":"67","author":"Ahmed N.","year":"2005","unstructured":"Ahmed N.; Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 2005,67(1),3-21","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/10715762.2013.815348","volume":"47","author":"Vistoli G.","year":"2013","unstructured":"Vistoli G.; De Maddis D.; Cipak A.; Zarkovic N.; Carini M.; Aldini G.; Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation. Free Radic Res 2013,47(Suppl. 1),3-27","journal-title":"Free Radic Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2337\/db11-1120","volume":"61","author":"Nagai R.","year":"2012","unstructured":"Nagai R.; Murray D.B.; Metz T.O.; Baynes J.W.; Chelation: A fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 2012,61(3),549-559","journal-title":"Diabetes"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e0190509","DOI":"10.1371\/journal.pone.0190509","volume":"13","author":"Rasheed S.","year":"2018","unstructured":"Rasheed S.; S&#xE1;nchez S.S.; Yousuf S.; Honor&#xE9; S.M.; Choudhary M.I.; Drug repurposing: In-vitro anti-glycation properties of 18 common drugs. PLoS One 2018,13(1),e0190509","journal-title":"PLoS One"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nrd895","volume":"1","author":"Johnson T.O.","year":"2002","unstructured":"Johnson T.O.; Ermolieff J.; Jirousek M.R.; Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 2002,1(9),696-709","journal-title":"Nat Rev Drug Discov"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2337\/diabetes.52.1.21","volume":"52","author":"Gum R.J.","year":"2003","unstructured":"Gum R.J.; Gaede L.L.; Koterski S.L.; Heindel M.; Clampit J.E.; Zinker B.A.; Trevillyan J.M.; Ulrich R.G.; Jirousek M.R.; Rondinone C.M.; Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob\/ob mice. Diabetes 2003,52(1),21-28","journal-title":"Diabetes"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"23829","DOI":"10.1074\/jbc.M609680200","volume":"282","author":"Xue B.","year":"2007","unstructured":"Xue B.; Kim Y.B.; Lee A.; Toschi E.; Bonner-Weir S.; Kahn C.R.; Neel B.G.; Kahn B.B.; Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. J Biol Chem 2007,282(33),23829-23840","journal-title":"J Biol Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41392-020-00440-z","volume":"6","author":"Liu D.","year":"2021","unstructured":"Liu D.; Gao Y.; Liu J.; Huang Y.; Yin J.; Feng Y.; Shi L.; Meloni B.P.; Zhang C.; Zheng M.; Gao J.; Intercellular mitochondrial transfer as a means of tissue revitalization. Signal Transduct Target Ther 2021,6(1),65","journal-title":"Signal Transduct Target Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.drudis.2007.03.011","volume":"12","author":"Zhang S.","year":"2007","unstructured":"Zhang S.; Zhang Z.Y.; PTP1B as a drug target: Recent developments in PTP1B inhibitor discovery. Drug Discov Today 2007,12(9-10),373-381","journal-title":"Drug Discov Today"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0001-2092(06)61065-X","volume":"76","author":"Bailes B.K.","year":"2002","unstructured":"Bailes B.K.; Diabetes mellitus and its chronic complications. AORN J 2002,76(2),266-276","journal-title":"AORN J"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.2337\/dc14-0865","volume":"37","author":"Avogaro A.","year":"2014","unstructured":"Avogaro A.; Fadini G.P.; The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications. Diabetes Care 2014,37(10),2884-2894","journal-title":"Diabetes Care"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/138955710791331007","volume":"10","author":"Tundis R.","year":"2010","unstructured":"Tundis R.; Loizzo M.R.; Menichini F.; Natural products as &#x3B1;-amylase and &#x3B1;-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: An update. Mini Rev Med Chem 2010,10(4),315-331","journal-title":"Mini Rev Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"31113","DOI":"10.1039\/C4RA14211J","volume":"5","author":"Chinchansure A.A.","year":"2015","unstructured":"Chinchansure A.A.; Korwar A.M.; Kulkarni M.J.; Joshi S.P.; Recent development of plant products with anti-glycation activity: A review. RSC Adv 2015,5(39),31113-31138","journal-title":"RSC Adv"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.phytochem.2017.10.003","volume":"145","author":"Costa E.V.","year":"2018","unstructured":"Costa E.V.; Soares L.N.; Pinheiro M.L.B.; Maia B.H.L.N.S.; Marques F.A.; Barison A.; Almeida J.R.G.S.; Sousa I.L.; Galaverna R.S.; Heerdt G.; Morgon N.H.; Acho L.D.R.; Lima E.S.; da Silva F.M.A.; Koolen H.H.F.; Guaianolide sesquiterpene lactones and aporphine alkaloids from the stem bark of Guatteria friesiana. Phytochemistry 2018,145,18-25","journal-title":"Phytochemistry"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/hlca.200800365","volume":"92","author":"Li Y-K.","year":"2009","unstructured":"Li Y-K.; Zhao Q-J.; Hu J.; Zou Z.; He X-Y.; Yuan H-B.; Shi X-Y.; Two new quinoline alkaloid mannopyranosides from Solidago canadensis. Helv Chim Acta 2009,92(5),928-931","journal-title":"Helv Chim Acta"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0731-7085(03)00207-3","volume":"32","author":"Ap&#xE1;ti P.","year":"2003","unstructured":"Ap&#xE1;ti P.; Szentmih&#xE1;lyi K.; Krist&#xF3; S.T.; Papp I.; Vinkler P.; Szoke E.; K&#xE9;ry A.; Herbal remedies of Solidago-correlation of phytochemical characteristics and antioxidative properties. J Pharm Biomed Anal 2003,32(4-5),1045-1053","journal-title":"J Pharm Biomed Anal"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.indcrop.2014.10.015","volume":"63","author":"Radvaien J.","year":"2015","unstructured":"Radvaien J.; Marska M.; Ivanauskas L.; Jakstas V.; Karpavj ieo, B. Assessment of phenolic compound accumulation in two widespread goldenrods. Ind Crops Prod 2015,63,158-166","journal-title":"Ind Crops Prod"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biopha.2016.12.058","volume":"87","author":"Tang D.","year":"2017","unstructured":"Tang D.; Chen Q.B.; Xin X.L.; Aisa H.A.; Anti-diabetic effect of three new norditerpenoid alkaloids in vitro and potential mechanismvia PI3K\/Akt signaling pathway. Biomed Pharmacother 2017,87,145-152","journal-title":"Biomed Pharmacother"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1039\/C7FO01489A","volume":"9","author":"Yang Z.","year":"2018","unstructured":"Yang Z.; Wu F.; He Y.; Zhang Q.; Zhang Y.; Zhou G.; Yang H.; Zhou P.; A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway. Food Funct 2018,9(1),397-406","journal-title":"Food Funct"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/s2175-97902019000417129","volume":"56","author":"Nawaz H.","year":"2020","unstructured":"Nawaz H.; Shad M.A.; Rehman N.; Andaleeb H.; Ullah N.; Effect of solvent polarity on extraction yield and antioxidant properties of phytochemicals from bean (Phaseolus vulgaris) seeds. Braz J Pharm Sci 2020,56,1-9","journal-title":"Braz J Pharm Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/14786419.2019.1637874","volume":"34","author":"Daliu P.","year":"2020","unstructured":"Daliu P.; Annunziata G.; Tenore G.C.; Santini A.; Abscisic acid identification in Okra, Abelmoschus esculentus L. (Moench): Perspective nutraceutical use for the treatment of diabetes. Nat Prod Res 2020,34(1),3-9","journal-title":"Nat Prod Res"},{"key":"ref=25","first-page":"2863","volume":"5","author":"Shai L.L.","year":"2011","unstructured":"Shai L.L.; Inhibitory effects of five medicinal plants on rat alpha-glucosidase: Comparison with their effects on yeast alpha-glucosidase. J Med Plants Res 2011,5,2863-2867","journal-title":"J Med Plants Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/14756361003733621","volume":"26","author":"Choudhary M.I.","year":"2011","unstructured":"Choudhary M.I.; Abbas G.; Ali S.; Shuja S.; Khalid N.; Khan K.M.; Atta-ur-Rahman; Basha, F.Z. Substituted benzenediol Schiff bases as promising new anti-glycation agents. J Enzyme Inhib Med Chem 2011,26(1),98-103","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1021\/np400533h","volume":"76","author":"Nguyen P.H.","year":"2013","unstructured":"Nguyen P.H.; Yang J.L.; Uddin M.N.; Park S.L.; Lim S.I.; Jung D.W.; Williams D.R.; Oh W.K.; Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity. J Nat Prod 2013,76(11),2080-2087","journal-title":"J Nat Prod"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1021\/np5005856","volume":"78","author":"Nguyen P.H.","year":"2015","unstructured":"Nguyen P.H.; Zhao B.T.; Ali M.Y.; Choi J.S.; Rhyu D.Y.; Min B.S.; Woo M.H.; Insulin-mimetic selaginellins from Selaginella tamariscina with protein tyrosine phosphatase 1B (PTP1B) inhibitory activity. J Nat Prod 2015,78(1),34-42","journal-title":"J Nat Prod"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"36642","DOI":"10.1021\/acsami.7b12233","volume":"9","author":"Yao Q.","year":"2017","unstructured":"Yao Q.; Choi J.H.; Dai Z.; Wang J.; Kim D.; Tang X.; Zhu L.; Improving tumor specificity and anticancer activity of dasatinib by dual-targeted polymeric micelles. ACS Appl Mater Interfaces 2017,9(42),36642-36654","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1373\/clinchem.2008.104844","volume":"54","author":"Dubowski K.M.","year":"2008","unstructured":"Dubowski K.M.; An o-toluidine method for body-fluid glucose determination. Clin Chem 2008,54(11),1919-1920","journal-title":"Clin Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2105-7-85","volume":"7","author":"Yuan J.S.","year":"2006","unstructured":"Yuan J.S.; Reed A.; Chen F.; Stewart C.N.; Statistical analysis of real-time PCR data. BMC Bioinfor 2006,7(1),85","journal-title":"BMC Bioinfor"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"Schindelin J.","year":"2012","unstructured":"Schindelin J.; Arganda-Carreras I.; Frise E.; Kaynig V.; Longair M.; Pietzsch T.; Preibisch S.; Rueden C.; Saalfeld S.; Schmid B.; Tinevez J-Y.; White D.J.; Hartenstein V.; Eliceiri K.; Tomancak P.; Cardona A.; Fiji: An open-source platform for biological-image analysis. Nat Methods 2012,9(7),676-682","journal-title":"Nat Methods"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1556\/APhysiol.101.2014.4.2","volume":"101","author":"Ghasemi A.","year":"2014","unstructured":"Ghasemi A.; Khalifi S.; Jedi S.; Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol Hung 2014,101(4),408-420","journal-title":"Acta Physiol Hung"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/jcm8091332","volume":"8","author":"Vieira R.","year":"2019","unstructured":"Vieira R.; Souto S.B.; S&#xE1;nchez-L&#xF3;pez E.; Machado A.L.; Severino P.; Jose S.; Santini A.; Silva A.M.; Fortuna A.; Garc&#xED;a M.L.; Souto E.B.; Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome-strategies forin vivo administration: part-II. J Clin Med 2019,8(9),1332","journal-title":"J Clin Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cbi.2010.09.019","volume":"188","author":"Lee J.","year":"2010","unstructured":"Lee J.; Yee S.T.; Kim J.J.; Choi M.S.; Kwon E.Y.; Seo K.I.; Lee M.K.; Ursolic acid ameliorates thymic atrophy and hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice. Chem Biol Interact 2010,188(3),635-642","journal-title":"Chem Biol Interact"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/10915810600961531","volume":"25","author":"Gad S.C.","year":"2006","unstructured":"Gad S.C.; Cassidy C.D.; Aubert N.; Spainhour B.; Robbe H.; Nonclinical vehicle use in studies by multiple routes in multiple species. Int J Toxicol 2006,25(6),499-521","journal-title":"Int J Toxicol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1742-7843.2006.pto_241.x","volume":"98","author":"Kamalakkannan N.","year":"2006","unstructured":"Kamalakkannan N.; Prince P.S.M.; Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin Pharmacol Toxicol 2006,98(1),97-103","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"Workman P.","year":"2010","unstructured":"Workman P.; Aboagye E.O.; Balkwill F.; Balmain A.; Bruder G.; Chaplin D.J.; Double J.A.; Everitt J.; Farningham D.A.; Glennie M.J.; Kelland L.R.; Robinson V.; Stratford I.J.; Tozer G.M.; Watson S.; Wedge S.R.; Eccles S.A.; Guidelines for the welfare and use of animals in cancer research. Br J Cancer 2010,102(11),1555-1577","journal-title":"Br J Cancer"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"h102","DOI":"10.1136\/bmj.h102","volume":"350","author":"Balsells M.","year":"2015","unstructured":"Balsells M.; Garc&#xED;a-Patterson A.; Sol&#xE0; I.; Roqu&#xE9; M.; Gich I.; Corcoy R.; Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-analysis. BMJ 2015,350,h102","journal-title":"BMJ"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2165\/00003495-200059030-00012","volume":"59","author":"Scott L.J.","year":"2000","unstructured":"Scott L.J.; Spencer C.M.; Miglitol: A review of its therapeutic potential in type 2 diabetes mellitus. Drugs 2000,59(3),521-549","journal-title":"Drugs"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2202\/1553-3840.1483","volume":"8","author":"Kuppusamy A.","year":"2011","unstructured":"Kuppusamy A.; Muthusamy U.; Thirumalaisamy S.A.; Varadharajan S.; Ramasamy K.; Ramanathan S.; In vitro (&#x3B1;-glucosidase and &#x3B1;-amylase inhibition) and in vivo antidiabetic property of phytic acid (IP6) in streptozotocin- nicotinamide-induced type 2 diabetes mellitus (NIDDM) in rats. J Complement Integr Med 2011,8,8","journal-title":"J Complement Integr Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/0974-8490.188883","volume":"8","author":"Dzib-Guerra W.D.","year":"2016","unstructured":"Dzib-Guerra W.D.; Escalante-Erosa F.; Garc&#xED;a-Sosa K.; Derbr&#xE9; S.; Blanchard P.; Richomme P.; Pe&#xF1;a-Rodr&#xED;guez L.M.; Anti-Advanced glycation end-product and free radical scavenging activity of plants from the Yucatecan flora. Pharmacognosy Res 2016,8(4),276-280","journal-title":"Pharmacognosy Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","volume":"18","author":"Singh V.P.","year":"2014","unstructured":"Singh V.P.; Bali A.; Singh N.; Jaggi A.S.; Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 2014,18(1),1-14","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2007.03.006","volume":"5","author":"Huang S.","year":"2007","unstructured":"Huang S.; Czech M.P.; The GLUT4 glucose transporter. Cell Metab 2007,5(4),237-252","journal-title":"Cell Metab"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/biof.1085","volume":"39","author":"Ueda M.","year":"2013","unstructured":"Ueda M.; Hayashibara K.; Ashida H.; Propolis extract promotes translocation of glucose transporter 4 and glucose uptake through both PI3K- and AMPK-dependent pathways in skeletal muscle. Biofactors 2013,39(4),457-466","journal-title":"Biofactors"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jneumeth.2011.02.011","volume":"197","author":"Codeluppi S.","year":"2011","unstructured":"Codeluppi S.; Gregory E.N.; Kjell J.; Wigerblad G.; Olson L.; Svensson C.I.; Influence of rat substrain and growth conditions on the characteristics of primary cultures of adult rat spinal cord astrocytes. J Neurosci Methods 2011,197(1),118-127","journal-title":"J Neurosci Methods"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"11132","DOI":"10.1074\/jbc.M110.202283","volume":"286","author":"Pontarin G.","year":"2011","unstructured":"Pontarin G.; Ferraro P.; Rampazzo C.; Kollberg G.; Holme E.; Reichard P.; Bianchi V.; Deoxyribonucleotide metabolism in cycling and resting human fibroblasts with a missense mutation in p53R2, a subunit of ribonucleotide reductase. J Biol Chem 2011,286(13),11132-11140","journal-title":"J Biol Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"C1171","DOI":"10.1152\/ajpcell.00514.2009","volume":"299","author":"Ching J.K.","year":"2010","unstructured":"Ching J.K.; Rajguru P.; Marupudi N.; Banerjee S.; Fisher J.S.; A role for AMPK in increased insulin action after serum starvation. Am J Physiol Cell Physiol 2010,299(5),C1171-C1179","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=49","first-page":"195","volume":"6","author":"Tyagi T.","year":"2017","unstructured":"Tyagi T.; Mala A.; Phytochemical and GC-MS analysis of bioactive constituents in the ethanolic of Pistia stratiotes L. and Eichhornia crassipes (Mart.) solms. J Pharmacogn Phytochem 2017,6,195-206","journal-title":"J Pharmacogn Phytochem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.intimp.2007.01.008","volume":"7","author":"Moradali M.F.","year":"2007","unstructured":"Moradali M.F.; Mostafavi H.; Ghods S.; Hedjaroude G.A.; Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immunopharmacol 2007,7(6),701-724","journal-title":"Int Immunopharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF02977619","volume":"30","author":"Yoo Y.C.","year":"2007","unstructured":"Yoo Y.C.; Shin B.H.; Hong J.H.; Lee J.; Chee H.Y.; Song K.S.; Lee K.B.; Isolation of fatty acids with anticancer activity from Protaetia brevitarsis larva. Arch Pharm Res 2007,30(3),361-365","journal-title":"Arch Pharm Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1080\/13813455.2020.1722705","volume":"128","author":"Sanad F.A.","year":"2022","unstructured":"Sanad F.A.; Ahmed S.F.; El-Tantawy W.H.; Antidiabetic and hypolipidemic potentials of Solidago virgaurea extract in alloxan-induced diabetes type 1. Arch Physiol Biochem 2022,128,716-723","journal-title":"Arch Physiol Biochem"},{"key":"ref=53","first-page":"274","volume":"8","author":"Demir H.","year":"2009","unstructured":"Demir H.; A&#xE7;\u0131k, L.; Bali, E.; G&#xF6;nder, L.; Kaynak, G. Antioxidant and antimicrobial activities of Solidago virgaurea extracts. Afr J Biotechnol 2009,8,274-279","journal-title":"Afr J Biotechnol"}],"container-title":["Current Bioactive Compounds"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573407218666220615143502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/206034\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573407218666220615143502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T04:19:33Z","timestamp":1679977173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/206034\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573407218666220615143502","relation":{},"ISSN":["1573-4072"],"issn-type":[{"type":"print","value":"1573-4072"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e150622206034"}}